Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.89 - $2.36 $144,993 - $384,477
162,914 New
162,914 $144,000
Q2 2023

Aug 14, 2023

BUY
$2.49 - $20.59 $258,429 - $2.14 Million
103,787 Added 244.98%
146,152 $394,000
Q1 2023

May 15, 2023

BUY
$15.95 - $25.18 $675,721 - $1.07 Million
42,365 New
42,365 $790,000
Q3 2022

Nov 14, 2022

BUY
$11.4 - $14.6 $524,833 - $672,154
46,038 Added 207.08%
68,270 $888,000
Q2 2022

Aug 15, 2022

BUY
$7.94 - $12.96 $176,522 - $288,126
22,232 New
22,232 $235,000
Q1 2022

May 16, 2022

SELL
$12.02 - $16.79 $212,213 - $296,427
-17,655 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$9.93 - $15.39 $561,710 - $870,566
-56,567 Reduced 76.21%
17,655 $249,000
Q3 2021

Nov 15, 2021

BUY
$10.18 - $26.64 $555,430 - $1.45 Million
54,561 Added 277.51%
74,222 $759,000
Q2 2021

Aug 16, 2021

SELL
$18.57 - $35.68 $326,627 - $627,575
-17,589 Reduced 47.22%
19,661 $524,000
Q1 2021

May 17, 2021

BUY
$31.0 - $55.72 $738,513 - $1.33 Million
23,823 Added 177.43%
37,250 $1.29 Million
Q4 2020

Feb 16, 2021

SELL
$37.09 - $48.97 $428,055 - $565,162
-11,541 Reduced 46.22%
13,427 $498,000
Q3 2020

Nov 16, 2020

BUY
$40.47 - $45.5 $728,338 - $818,863
17,997 Added 258.17%
24,968 $1.03 Million
Q2 2020

Aug 14, 2020

BUY
$32.57 - $42.83 $227,045 - $298,567
6,971 New
6,971 $283,000
Q1 2020

May 15, 2020

SELL
$23.3 - $45.96 $1.33 Million - $2.61 Million
-56,887 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$34.58 - $48.06 $1.97 Million - $2.73 Million
56,887 New
56,887 $2.44 Million
Q1 2019

May 15, 2019

SELL
$42.83 - $59.91 $2.21 Million - $3.1 Million
-51,663 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$37.97 - $60.16 $1.96 Million - $3.11 Million
51,663 New
51,663 $2.39 Million
Q4 2017

Feb 14, 2018

SELL
$41.95 - $60.1 $295,831 - $423,825
-7,052 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$33.4 - $53.9 $235,536 - $380,102
7,052
7,052 $379,000

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.